Skip to content

Absorption Kinetics of Polyphenols in Angel's Plant (Angelica Keiskei)

Absorption Kinetics of Polyphenols in Angel's Plant (Angelica Keiskei)

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00721643
Enrollment
10
Registered
2008-07-24
Start date
2008-07-31
Completion date
2010-12-31
Last updated
2017-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oxidative Stress

Keywords

Angelica keiskei, absorption kinetics, quercetin

Brief summary

The absorption kinetics of polyphenols in angel's plant (Angelica keiskei), which is a dark green leafy vegetable rich in antioxidant nutrients, will be determined in older adults in this pilot study.

Interventions

DIETARY_SUPPLEMENTangel's plant (Angelica keiskei)

Healthy control, one time dose of 5g dry power of Angelica keiskei

DIETARY_SUPPLEMENTAngel's plant (Angelica keiskei)

Metaboic syndrome subjects, one time dose of 5g dry powder of angel's plant (Angelica keiskei)

Sponsors

Tufts University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Healthy subjects (\>60 yr, n=5) * subjects with metabolic syndrome (\>60 yr, n=5) * Subjects who has * high fasting plasma glucose (\>5.6 mmol/L), * central obesity (waist-hip ratio, \>0.9 for men, \>0.85 for women) * either high blood pressure (\>130/85 mmHg) or high triacylglycerol (\>1.7 mmol/L) will be selected to have metabolic syndrome. * normal hematological parameters, normal serum albumin, normal liver function, and normal kidney function * no history of smoking or alcoholism.

Exclusion criteria

* consume \>7 alcoholic drinks/wk * taking cholesterol medication or hormone replacement

Design outcomes

Primary

MeasureTime frame
Plasma quercetin0, 30, 60, 100, 180, 240, 300, 360, 420 & 480 min

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026